← Back
$PMVP All transactions

PMV Pharmaceuticals, Inc.

▼ SELL

$ Value

$62K

Shares

58,411

Price

$1

Filed

Jul 3

Insider

Name

Mack David Henry

Title

President and CEO

CIK

0001341642

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

536,133

Footnotes

The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. | Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. | The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. | The shares are held of record by the Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein. | The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.

Filing Info

Accession No.

0001415889-25-019380

Form Type

4

Issuer CIK

0001699382

Mack David Henry's History

Date Ticker Type Value
2025-10-27 PMVP M $302K
2025-10-27 PMVP M $0
2025-07-01 PMVP $62K

Other Insiders at PMVP (90d)

No other insider activity at this issuer in the last 90 days.